Despite clinical trial data showing inferior vena cava (IVC) filters are ineffective for reducing mortality following deep vein thrombosis (DVT), as well as guideline recommendations against their use ...
LOS ANGELES, CA, UNITED STATES, February 10, 2026 /EINPresswire.com/ -- Pulmonary embolisms affect 370,000 patients per ...
Wide variation exists in the use of inferior vena cava filters for the treatment of venous thromboembolism, possibly because of a deficit of evidence on the efficacy of these devices, and a lack of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Patients with venous thromboembolism and ...
Filters are frequently used for the first episode of VTE, either with or without concomitant anticoagulation, and insertion of a filter has been recommended for cancer patients with recurrent VTE ...
Use of inferior vena cava filters is associated with a lower risk of short-term mortality only in the small subgroup of patients hospitalized with acute venous thromboembolism (VTE) who have a ...
The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...
August 11, 2010 (Rockville, Maryland and York, Pennsylvania) — The Food and Drug Administration (FDA) has received more than 900 reports of adverse events with inferior vena cava (IVC) filters, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results